Impact of Novartis’ rebate trial result in pharma industry
While the amendments to the Pharmaceutical Affairs Law and Medical Device Law to tighten punishment for pharmaceutical and medical device companies providing illegal rebates passed the National Assembly plenary session on the 17th, the final result of the Novartis’ rebate trial is expected to bec...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
